Reticulocyte mitochondrial retention increases reactive oxygen species and oxygen consumption in mouse models of sickle cell disease and phlebotomy-induced anemia
Experimental Hematology · 2023
DOI: 10.1016/j.exphem.2023.02.005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Experimental Hematology, 2023. Verfasst von Anne Gallivan und 11 weiteren Autor:innen. Beteiligte Einrichtung: UCSF Benioff Children's Hospital Oakland, Oakland, CA. Hauptthemen laut MEDLINE: Reticulocytes, Anemia, Sickle Cell. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, NCCIH NIH HHS, NHLBI.
Abstract (Originalsprache)
Sickle cell disease (SCD) is caused by a mutation of the β-globin gene that results in the production of hemoglobin S (HbS). People with SCD experience anemia, severe acute pain episodes, persistent chronic pain, multiorgan damage, and a reduced life span. The pathophysiology of SCD caused by the polymerization of HbS on deoxygenation results in red cell deformability and the generation of reactive oxygen species (ROS). These 2 factors lead to red cell fragility and hemolysis. Reticulocytosis is an independent predictor of disease morbidity and mortality in SCD. We previously established that humans and mice with SCD exhibit abnormal mitochondrial retention in erythrocytes increasing ROS-associated hemolysis. Here, we investigated the hypothesis that mitochondrial retention and increased ROS are a consequence of stress erythropoiesis. Our results show clearly that stress erythropoiesis in phlebotomized, anemic AA mice results in mitochondrial retention and increased ROS in reticulocytes. We observed that elevated mitochondrial retention in reticulocytes also alters oxygen consumption and potentially contributes to increased HbS polymerization and red blood cell hemolysis. Therefore, these events occurring due to stress erythropoiesis contribute significantly to the pathology of SCD and suggest new therapeutic targets.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- UCSF Benioff Children's Hospital Oakland, Oakland, CA.
- University of Illinois at Chicago, Chicago, IL.
- University of Illinois at Chicago, Chicago, IL; Jesse Brown VA Medical Center, Chicago, IL.
- UCSF Benioff Children's Hospital Oakland, Oakland, CA. Electronic address: angela.rivers@ucsf.edu.
Förderung
- NHLBI NIH HHS
- NCCIH NIH HHS
- NHLBI
- National Institutes of Health
Zitieren
APA
Gallivan, A., Alejandro, M., Kanu, A., Zekaryas, N., Horneman, H., Hong, L. K., Vinchinsky, E., Lavelle, D., Diamond, A. M., Molokie, R. E., Ramasamy, J., & Rivers, A. (2023). Reticulocyte mitochondrial retention increases reactive oxygen species and oxygen consumption in mouse models of sickle cell disease and phlebotomy-induced anemia. Experimental Hematology. https://doi.org/10.1016/j.exphem.2023.02.005
Vancouver
Gallivan A, Alejandro M, Kanu A, Zekaryas N, Horneman H, Hong LK, et al. Reticulocyte mitochondrial retention increases reactive oxygen species and oxygen consumption in mouse models of sickle cell disease and phlebotomy-induced anemia. Experimental Hematology. 2023. doi:10.1016/j.exphem.2023.02.005
BibTeX
@article{Gallivan2023,
author = {Gallivan, Anne and Alejandro, Mikail and Kanu, Amarachi and Zekaryas, Nebeyat and Horneman, Hart and Hong, Lenny K and Vinchinsky, Elliott and Lavelle, Don and Diamond, Alan M and Molokie, Robert E and Ramasamy, Jagadeesh and Rivers, Angela},
title = {Reticulocyte mitochondrial retention increases reactive oxygen species and oxygen consumption in mouse models of sickle cell disease and phlebotomy-induced anemia},
journal = {Experimental Hematology},
year = {2023},
doi = {10.1016/j.exphem.2023.02.005}
}
EUVIMED